• Business
  • Markets
  • Politics
  • Crypto
  • Finance
  • Intelligence
    • Policy Intelligence
    • Security Intelligence
    • Economic Intelligence
    • Fashion Intelligence
  • Energy
  • Technology
  • Taxes
  • Creator Economy
  • Wealth Management
  • LBNN Blueprints
  • Business
  • Markets
  • Politics
  • Crypto
  • Finance
  • Intelligence
    • Policy Intelligence
    • Security Intelligence
    • Economic Intelligence
    • Fashion Intelligence
  • Energy
  • Technology
  • Taxes
  • Creator Economy
  • Wealth Management
  • LBNN Blueprints

Verve gets FDA green light to expand base editing trial into US

Simon Osuji by Simon Osuji
March 24, 2025
in Technology
0
Verve gets FDA green light to expand base editing trial into US
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

The company expects next quarter to read out initial data from its Heart-2 trial, which is testing a one-time treatment for people with genetically elevated cholesterol.

Related posts

BreezeBio banks $60M to make more precise genetic medicines

BreezeBio banks $60M to make more precise genetic medicines

February 25, 2026
LOTUS Bank, REA partner on N100bn renewable energy financing push – EnviroNews

LOTUS Bank, REA partner on N100bn renewable energy financing push – EnviroNews

February 25, 2026

Source link

Previous Post

DNA Testing Company 23andMe Files for Bankruptcy, CEO Leaves

 Next Post

Top 10 African solar markets by new solar installation
Next Post
Top 10 African solar markets by new solar installation

Top 10 African solar markets by new solar installation

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED NEWS

Nvidia marks Paris tech fair with Europe AI push

Nvidia marks Paris tech fair with Europe AI push

9 months ago
ChatGPT’s New Upgrade Teases AI’s Multimodal Future

ChatGPT’s New Upgrade Teases AI’s Multimodal Future

2 years ago
Inspiring story of Fridah Nyakundi

Inspiring story of Fridah Nyakundi

2 years ago
‘We Are Not Programmed to Die,’ Says Nobel Laureate Venki Ramakrishnan

‘We Are Not Programmed to Die,’ Says Nobel Laureate Venki Ramakrishnan

11 months ago

POPULAR NEWS

  • Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

    Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

    0 shares
    Share 0 Tweet 0

  • The world’s top 10 most valuable car brands in 2025

    0 shares
    Share 0 Tweet 0

  • Top 10 African countries with the highest GDP per capita in 2025

    0 shares
    Share 0 Tweet 0

  • Global ranking of Top 5 smartphone brands in Q3, 2024

    0 shares
    Share 0 Tweet 0

  • When Will SHIB Reach $1? Here’s What ChatGPT Says

    0 shares
    Share 0 Tweet 0

Get strategic intelligence you won’t find anywhere else. Subscribe to the Limitless Beliefs Newsletter for monthly insights on overlooked business opportunities across Africa.

Subscription Form

© 2026 LBNN – All rights reserved.

Privacy Policy | About Us | Contact

Tiktok Youtube Telegram Instagram Linkedin X-twitter
No Result
View All Result
  • Home
  • Business
  • Politics
  • Markets
  • Crypto
  • Economics
    • Manufacturing
    • Real Estate
    • Infrastructure
  • Finance
  • Energy
  • Creator Economy
  • Wealth Management
  • Taxes
  • Telecoms
  • Military & Defense
  • Careers
  • Technology
  • Artificial Intelligence
  • Investigative journalism
  • Art & Culture
  • LBNN Blueprints
  • Quizzes
    • Enneagram quiz
  • Fashion Intelligence

© 2023 LBNN - All rights reserved.